(Q44163603)

30 November 2017

Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients (English)

1 reference

30 November 2017

0 references

Jason Chia-Hsien Cheng

1

1 reference

30 November 2017

Mei-Ching Liu

2

1 reference

30 November 2017

Stella Y Tsai

3

1 reference

30 November 2017

Wei-Tse Fang

4

1 reference

30 November 2017

James Jer-Min Jian

5

1 reference

30 November 2017

Juei-Low Sung

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

30 November 2017

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

30 November 2017

101

1 reference

30 November 2017

9

1 reference

30 November 2017

2126-2133

1 reference

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

30 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

The use of 3-D dose volume analysis to predict radiation hepatitis

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCNCR.20591

21 January 2018

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Surgical results in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Analysis of radiation-induced liver disease using the Lyman NTCP model.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Preoperative chemoradiation for adenocarcinoma of the pancreas: Excessive toxicity of prophylactic hepatic irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Hepatic toxicity resulting from cancer treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20591

7 January 2021

Identifiers

DOI

10.1002/CNCR.20591

1 reference

30 November 2017

1 reference